Le Lézard
Classified in: Science and technology
Subject: Business Update

Smith Micro Regains Compliance with Nasdaq Minimum Bid Price Requirement


Smith Micro Software, Inc. (Nasdaq: SMSI) ("Smith Micro" or the "Company"), announced today that it has received notice from The Nasdaq Stock Market informing the Company that, after having a closing bid price at or greater than $1.00 per share for 12 consecutive business days from April 11, 2024 to April 26, 2024, the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market, and that the matter is now closed.

About Smith Micro Software, Inc.

Smith Micro develops software to simplify and enhance the mobile experience, providing solutions to some of the leading wireless service providers around the world. From enabling the digital family lifestyle to providing powerful voice messaging capabilities, Smith Micro's solutions enrich today's connected lifestyles while creating new opportunities to engage consumers via smartphones and consumer IoT devices. The Smith Micro portfolio also includes a wide range of products for creating, sharing, and monetizing rich content, such as visual voice messaging, optimizing retail content display and performing analytics on any product set. For more information, visit www.smithmicro.com.

Smith Micro and the Smith Micro logo are registered trademarks or trademarks of Smith Micro Software, Inc.


These press releases may also interest you

at 15:38
When Prof. Po-Shen Loh took the stage in front of thousands of people at the 2024 MathCON Finals, he saw an eager group, fittingly, looking for answers....

at 15:34
When Prof. Po-Shen Loh took the stage in front of thousands of people at the 2024 MathCON Finals, he saw an eager group, fittingly, looking for answers....

at 15:33
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA granted accelerated approval to tarlatamab-dlle (Imdelltra, Amgen, Inc.) for extensive stage small cell lung cancer...

at 15:30
When Prof. Po-Shen Loh took the stage in front of thousands of people at the 2024 MathCON Finals, he saw an eager group, fittingly, looking for answers....

at 15:24
When Prof. Po-Shen Loh took the stage in front of thousands of people at the 2024 MathCON Finals, he saw an eager group, fittingly, looking for answers....

at 15:06
As law enforcement...



News published on and distributed by: